Concepedia

Natacha Bordry

NB

9

Publications

1.1K

Citations

9

H-Index

2014

Active since

Affiliations

Ludwig Cancer Research(Current)

University of Lausanne

École Polytechnique Fédérale de Lausanne

University of Chicago

Hôpital Orthopédique de la Suisse Romande

Natacha Bordry is an author at Ludwig Cancer Research specializing in medicine, radiation oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2014–2022

9

Publications

9

T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

Natalie J. Neubert, Martina Schmittnaegel, Natacha Bordry et al. · Science Translational Medicine · 2018 · 292 citations · Full text

Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma

Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin et al. · Science Translational Medicine · 2017 · 237 citations · Full text

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

Alfredo Addeo, Pankil Shah, Natacha Bordry et al. · Cancer Cell · 2021 · 234 citations · Full text

, , +8

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

Maria A.S. Broggi, Léa Maillat, Cristina C. Clement et al. · The Journal of Experimental Medicine · 2019 · 125 citations · Full text

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients

T. J. Murray, Silvia A. Fuertes Marraco, Petra Baumgaertner et al. · Frontiers in Immunology · 2016 · 97 citations · Full text

Rows per page

1–5 of 9